Neuro-Bio and the Belgian Economic Mission to the United Kingdom.
During the week beginning on the 9th of May, Neuro-Bio' CEO and Operations Director, Susan Greenfield and Sara Garcia-Rates, participated at the events organised by the Belgian Economic Mission to the United Kingdom held in London and Oxford. Click the link for more...
Neuro-Bio’s CEO debate at the House of Lords.
On Tuesday the 17th of May, Neuro-Bio's CEO, Baroness Susan Greenfield, had a debate at the House of Lords, in London. The principal topics for the debate will be education, welfare, health and public services, therefore Susan Greenfield will be talking about the...
Neuro-Bio participates at the ‘Human Library Event’ at the Europa School, Culham
On Thursday 12th May Neuro-Bio was part of the Human Library event organised by the Europa School Careers department at the Europa School in Culham (https://www.linkedin.com/in/europa-school-careers-department-9912a31b8/). The aim of the event was to introduce 12-13...
Sampled CEO & Chief Strategy Officer visit Neuro-Bio.
On Thursday the 28th of April Robin Grimwood and Benedict Roylance from Sampled visited Neuro-Bio to discuss future plans. It was a very exciting and informative meeting.
Georgia Price joins Neuro-Bio!
Neuro-bio welcomes Georgia Price as part of the team! Georgia is currently undertaking a DPhil at the University of Oxford studying neurodegenerative diseases after completing her undergraduate degree in Biomedical Science from the University of Sheffield. After...
Neuro-Bio Press Conference Royal College of Physicians London, 05/04/2022
On Tuesday the 5th of April, Neuro-bio's CEO, Baroness Susan Greenfield, NED, Professor Paul Herrling and Behaviourist, Stuart Williams, held a Press Conference at the Royal College of Physicians London for the publication of their latest results in Alzheimer’s &...
Linda Morgan joins Neuro-Bio !
Neuro-Bio welcomes Linda Morgan as new Finance Manager. Linda has a wide range of experience in accountancy. After graduating from the University of Brighton with a BA (hons) degree in Accounting and Finance she went on to work for an accounting practice in Oxford...
Novel Drug from Neuro-Bio effective in a mouse model of Alzheimer’s disease
Publishing our work in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), Neuro-Bio researchers, in collaboration with the drug discovery company Evotec SE, UCLA, and King’s College London studied the ability of their patented...
Neuro-Bio and Tino Rossi are now collaborating together.
Neuro-Bio is now collaborating with Tino Rossi. Tino has over 40 years of experience in drug discovery and development having occupied roles of growing seniority and leadership in Medicinal Chemistry, Chemical Development and Preclinical Drug Discovery in the...
Mark I. Butler joins Neuro-Bio!
Neuro-Bio welcomes Mark I. Butler as new COO Designate. Mark holds a Ph.D. in Pharmacology from the University of Bristol, where he completed a "bench-to-bedside'' thesis focusing on the mechanisms of new antiplatelet agents. He has over ten years experience managing...
